AstraZeneca Fails to Win FDA Approval; Cephalon CEO Dies

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

Dec. 17 (Bloomberg) -- Bloomberg's Shannon Pettypiece discusses today's top health stories, including AstraZeneca Plc's failure to win U.S. approval for its new Brilinta blood thinner and the death of Cephalon Inc. Chief Executive Officer Frank Baldino Jr. Pettypiece speaks with Scarlet Fu on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change